Expert Review of Molecular Diagnostics

Article	Citations
Do small RNAs have potential in disease diagnosis and treatment?	67
Cost analyses for malaria molecular diagnosis for research planners in India and beyond	62
Gene fusions in vascular tumors and their underlying molecular mechanisms	58
Alzheimer’s disease: a scoping review of biomarker research and development for effective disease diagnosis	51
Clinicopathological, etiological and molecular characteristics of intrahepatic cholangiocarcinoma subtypes classified by mucin production and immunohistochemical features	46
Metabolic profile of the Warburg effect as a tool for molecular prognosis and diagnosis of cancer	33
Analytical validation of a novel multi-target blood-based test to detect hepatocellular carcinoma	33
Polygenic and Network-based studies in risk identification and demystification of cancer	32
Mild behavioral impairment and neurodegeneration: time for a biomarker-based assessment	30
Evolution and future of cervical cancer screening: from cytology to primary HPV testing and the impact of vaccination	29
Retrospective analysis of the risk factors associated with failure in obtaining effective noninvasive prenatal test results and pregnancy outcomes: a case-control study	28
Cancer cell-derived extracellular vesicles activate hepatic stellate cells in colorectal cancer	28
Molecular charcterization of lung adenocarcinoma combining whole exome sequencing, copy number analysis and gene expression profiling	25
Molecular point-of-care testing in the community pharmacy setting: current status and future prospects	25
Harnessing the potential of genomic characterization of mutational profiles to improve early diagnosis of lung cancer	24
Nuclease activity: an exploitable biomarker in bacterial infections	24
Evaluating tumor cell- and T cell-derived extracellular vesicles as potential biomarkers of cancer and immune cell competence	24
Recent updates in the development of molecular assays for the rapid identification and susceptibility testing of MRSA	23
Targeted RNA-sequencing for the evaluation of gene fusions in lung tumors: current status and future prospects	23
Unlocking the power of biomarkers: transforming the diagnosis of acute respiratory distress syndrome	23
The MALAT1-breast cancer interplay: insights and implications	22
The current and future applications of in situ hybridization technologies in anatomical pathology	22
Enzymatic cross-linking of collagens in organ fibrosis – resolution and assessment	22
RAD51 as a functional biomarker for homologous recombination deficiency in cancer: a promising addition to the HRD toolbox?	22
A novel anoikis-related signature predicts prognosis risk and treatment responsiveness in diffuse large B-cell lymphoma	20

Evaluation of molecular techniques to visceral leishmaniasis detection in asymptomatic patients: a systematic review	20
Functional proteomic analysis, a missing piece for understanding clonal evolution and cooperation in the tissue microecology	20
Neuroimaging with PET/CT in chronic traumatic encephalopathy: what nuclear medicine can do to move the field forward	19
Clinical application of noninvasive prenatal testing in twin pregnancies: a single-center experience	19
Emerging concepts in the detection of liver fibrosis in non-alcoholic fatty liver disease	18
Prognostic and survival impact of BCL9 and RPS6KB1 copy number variation detected from circulating free DNA in hepatocellular carcinoma	18
Long non-coding RNAs and their potential impact on diagnosis, prognosis, and therapy in prostate cancer: racial, ethnic, and geographical considerations	18
Noncoding RNAs as a potential biomarker for the prognosis of bladder cancer: a systematic review and meta-analysis	18
Bacterial extracellular vesicles in biofluids as potential diagnostic biomarkers	18
Common markers of testicular Sertoli cells	17
Predictive biomarkers of response to immune checkpoint inhibitors in hepatocellular carcinoma	17
The diagnostic accuracy of seven commercial molecular in vitro SARS-CoV-2 detection tests: a rapid meta-analysis	17
Genetic risk and gastric cancer: polygenic risk scores in population-based case-control study	17
Efficient screening strategies for severe combined immunodeficiencies in newborns	16
Early Identification of Fungal and Mycobacterium Infections in Pulmonary Granulomas Using Metagenomic Next-Generation Sequencing on Formalin fixation and paraffin embedding tissue	16
The clinical importance of high-sensitivity cardiac troponin measurements for risk prediction in non-cardiac surgery	16
The prognostic and diagnostic potential of kallikrein-related peptidases in ovarian cancer	16
Discovery of potential biomarkers for osteoporosis diagnosis by individual omics and multi-omics technologies	16
Molecular predictors of metastasis in patients with prostate cancer	16
Molecular diagnostic criteria of myeloproliferative neoplasms	15
Point-of-care isothermal nucleic acid amplification tests: progress and bottlenecks for extraction-free sample collection and preparation	15
Optimization of time interval for the measurement of plasma lipids for cardiovascular disease risk assessment	15
LncRNA NR2F1-AS1 as a potential biomarker for prognosis in cancer patients: meta and bioinformatics analysis	14
The challenges and potential in developing microRNA associated with regeneration as biomarkers to improve prognostication for liver failure syndromes and hepatocellular carcinoma	14
Comprehensive genomic profiling: a public health system perspective	14
Genomic determinants of biological aggressiveness and poor prognosis of pancreatic cancers: KRAS and beyond	14
Association between polymorphisms in TLR3 , TICAM1 and IFNA1 genes and covid-19 severity in Southern Brazil	13
Challenges associated with using extracellular vesicles as biomarkers in neurodegenerative disease	13
Reviewing the occurrence of large genomic rearrangements in patients with inherited cancer predisposing syndromes: importance of a comprehensive molecular diagnosis	13
Cystic echinococcosis microRNAs as potential noninvasive biomarkers: current insights and upcoming perspective	13
Biomarkers of sleep-wake disturbance as predictors of cognitive decline and accelerated disease progression	13
Patient outcomes improve when a molecular signature test guides treatment decision-making in rheumatoid arthritis	13
Characteristics of circRNA and its approach as diagnostic tool in melanoma	12
Cytokines as biomarkers of Huntington’s disease progression	12
Early diagnostics of fibromyalgia: an overview of the challenges and opportunities	12
Clinicopathologic and prognostic roles of circular RNA plasmacytoma variant translocation 1 in various cancers	12
Extracellular vesicles as source of biomarkers in hematological malignancies: looking towards clinical applications	12
Analytical validation of urine ALCAM ELISA as a test for lupus nephritis	12
Comparative evaluation of a dual-target real-time RT-PCR assay for COVID-19 diagnosis and assessment of performance in pooled saliva and nasopharyngeal swab samples	12
The role of molecular heterogeneity targeting resistance mechanisms to lung cancer therapies	12
Unraveling the future: hot topics shaping molecular diagnostics today	11
Quantitative versus qualitative estrogen and luteinizing hormone testing for personal fertility monitoring	11
Association betweenCDH1methylation and esophageal cancer risk: a meta-analysis and bioinformatics study	11
Prognostic biomarkers in melanoma: a 2023 update from clinical trials in different therapeutic scenarios	11
An update on utilising brain natriuretic peptide for risk stratification, monitoring and guiding therapy in heart failure	11
Faster infection diagnostics for intensive care unit (ICU) patients	11
Diagnostic approaches for dengue infection	11
Lessons from the pandemic: new best practices in selecting molecular diagnostics for point-of-care testing of infectious diseases in sub-Saharan Africa	10
Application of selected biosensor techniques in clinical diagnostics	10
COVID-19 diagnosis: lessons to learn and hints for preparedness	10

The association between blood sodium levels and survival in patients treated with immune checkpoint inhibitors	10
Current and emerging technologies to develop Point-of-Care Diagnostics in medical mycology	10
Decoding pancreatic cancer: key risk factors across genetics and lifestyle	10
Diagnostic salivary biomarkers in oral cancer and oral potentially malignant disorders and their relationships to risk factors – A systematic review	10
Genetic-based diagnostics of Parkinson’s disease and other Parkinsonian syndromes	10
Implications of TERT promoter mutations and telomerase activity in solid tumors with a focus on genitourinary cancers	10
Potential role of circulating miR-21 in the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis	10
The dark side of lipid metabolism in prostate and renal carcinoma: novel insights into molecular diagnostic and biomarker discovery	10
MicroRNA dysregulation in schistosomiasis-induced hepatic fibrosis: a systematic review	10
Mortality prediction of patients with spontaneous intracerebral hemorrhage by serum soluble Fas ligand concentrations	10
From detection to action: new diagnostic insights into antifungal resistance	10
Advances in pediatric sepsis biomarkers - what have we learnt so far?	9
Known biomarkers for monitoring pregnancy complications	9
The role of fecal biomarkers in individuals with inflammatory bowel disease	9
Potential use of heat shock protein 90 as a biomarker for the diagnosis of human diseases	9
An updated review of the role of lncRNAs and their contribution in various molecular subtypes of breast cancer	9
Recent developments in wearable & non-wearable point-of-care biosensors for cortisol detection	9
Molecular determination of insect venom allergies	9
Noninvasive prenatal screening in southeast China: clinical application and accuracy evaluation	9
Highlighting and addressing barriers to widespread adaptation of HIV self-testing in the United States	9
Association between NUDT17 polymorphisms and breast cancer risk	9
How our molecular understanding of the pathogenesis of Mycobacterium ulcerans infection can improve diagnosis of Buruli ulcer	9
JC polyomavirus: a short review of its biology, its association with progressive multifocal leukoencephalopathy, and the diagnostic value of different methods to manifest its activity or presence	9
Neuroimaging in hereditary spastic paraplegias: from qualitative cues to precision biomarkers	9
How reliable are polygenic risk scores for risk prediction in patients with heart disease?	8
Recent advances in rapid antimicrobial susceptibility testing systems	8
Future potential of metagenomics in microbiology laboratories	8
Towards improved point-of-care (POC) testing for patients with suspected sepsis: POC tests for host biomarkers and possible microbial pathogens	8
Variants of KLF5 and KLF12 were related to endometrial cancer risk in the Chinese population	8
One biomarker does not fit all: tailoring anti-infective therapy through utilization of procalcitonin and other specific biomarkers	8
Determining the accuracy of next generation sequencing based copy number variation analysis in Hereditary Breast and Ovarian Cancer	8
Statistical determination of cancer biomarkers: moving forward clinically	8
CD44v6 acts as a directional responding factor in the process of transcoelomic metastasis from gastric carcinoma to Krukenberg tumor	8
Correlation between lipoprotein-associated phospholipase A2 and poststroke mild cognitive impairment	7
TRIB3 overexpression predicts malignant progression and poor prognosis in human solid tumors: bioinformatics validation and clinical significance	7
Validating blood tests as a possible routine diagnostic assay of Alzheimer’s disease	7
Global polymorphism of Plasmodium falciparum histidine rich proteins 2/3 and impact on malaria rapid diagnostic test detection: a systematic review and meta-analysis	7
Point-of-care COVID-19 testing in the emergency department: current status and future prospects	7
Molecular techniques for the genomic viral RNA detection of West Nile, Dengue, Zika and Chikungunya arboviruses: a narrative review	7
Loop-mediated isothermal amplification for Candida species surveillance in under-resourced setting: a review of evidence	7
MicroRnas in preeclampsia	7
A charming molecular profile in the wrong tissue: the pathologist in the era of molecular diagnostics in the gastrointestinal tract	7
Cross-sectional risk models using quantitative fecal hemoglobin in colorectal cancer screening: a systematic review	7
Blood-based biomarkers of chronic inflammation	7
The status of standardization in methodologies for tear fluid biomarkers	7
Diagnostic and predictive value of liquid biopsy-derived exosome miR-21 for breast cancer: a systematic review and meta-analysis	7
Smartphone and wearable diagnostics	7
Point-of-care urine tenofovir monitoring of adherence to drive interventions for HIV treatment and prevention	7
Exploring the prognostic and predictive potential of bacterial biomarkers in non-gastrointestinal solid tumors	7
What are the diagnostic capabilities of glycans for breast cancer?	7
Dual-energy spectral CT in renal cell carcinoma: dawn of a brand-new era?	7
Applications of the CRISPR-Cas system for infectious disease diagnostics	7
A profile of the Visitect® CD4 and Visitect® CD4 advanced disease for management of people living with HIV	6
Creating standards for liquid biopsies: the BLOODPAC experience	6
Development and validation of a ligand–receptor pairs signature to predict outcome and provide a therapeutic strategy in gastric cancer	6
RT-LAMP in SARS-CoV-2 detection: point to improve primer designing and decrease molecular diagnosis pitfalls	6
Diagnostic significance of heart-type fatty acid-binding protein as a potential biomarker to predict the mortality rate of patients with sepsis: a systematic review and meta-analysis	6
Low-cost molecular methodology for blood group antigens identification and genotyping contribution to transfusion efficacy in multiple transfused patients	6
Evaluation of the performance of the BD MAX MDR-TB test in the diagnosis of Mycobacterium tuberculosis complex in extrapulmonary and pulmonary samples	6
Genetic variations as molecular diagnostic factors for idiopathic male infertility: current knowledge and future perspectives	6
Diagnostic accuracy of circulating-free DNA for the determination of hepatocellular carcinoma: a systematic review and meta-analysis	6
PCR diagnostic platforms for non- Aspergillus mold infections: ready for routine implementation in the clinic?	6
SSR4 as a prognostic biomarker and related with immune infiltration cells in colon adenocarcinoma	6
Retrospective analysis of persistent HyperCKemia with or without muscle weakness in a case series from Greece highlights vast DMD variant heterogeneity	6
Whole genome amplicon sequencing and phylogenetic analysis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from lineage B.1.36.27 isolated in Hong Kong	6
Detection of lung cancer and stages via breath analysis using a self-made electronic nose device	6
Next-generation sequencing for laboratory diagnosis of infectious diseases	6
An update on current and novel molecular diagnostics for the diagnosis of invasive fungal infections	6
Brain tumors and circulating micrornas: a systematic review and diagnostic meta-analysis	6
Diagnostic accuracy of CRISPR technology for detecting SARS-CoV-2: a systematic review and meta-analysis	6
Dual agonist–antagonist effect of ulipristal acetate in human endometrium and myometrium	6
Diagnostic accuracy of serum derived exosomes for hepatocellular carcinoma: a systematic review and meta-analysis	5
Diagnostic accuracy of clinically applied nanoparticle-based biosensors at detecting SARS-CoV-2 RNA and surface proteins in pharyngeal swabs compared to RT-PCR as a reference test	5
Borderline SARS-CoV-2 patients: the trace behind	5
The tumor immune microenvironment in pancreatic cancer and its potential in the identification of immunotherapy biomarkers	5
A sandwich chemiluminescent magnetic microparticle immunoassay for cryptococcal antigen detection	5
Peripheral blood biomarkers in monitoring treatment response in breast cancer patients	5
Practical considerations for pathological diagnosis and molecular profiling of cholangiocarcinoma: an expert review for best practices	5
Screening for oropharyngeal cancer: the time is now	5
Strengths and limitations of molecular diagnostics for Pneumocystis jirovecii pneumonia	5

Role of N6-methyladenosine modification in pathogenesis of ischemic stroke	5
The biomolecular corona of extracellular nanoparticles holds new promises for advancing clinical molecular diagnostics	5
Enhanced mitochondrial genome analysis: bioinformatic and long-read sequencing advances and their diagnostic implications	5
Liquid biopsy from research to clinical practice: focus on non-small cell lung cancer	5
Molecular testing as a tool to combat the COVID-19 pandemic	5
Viral metagenomic sequencing in the diagnosis of meningoencephalitis: a review of technical advances and diagnostic yield	5
α-synuclein as an emerging pathophysiological biomarker of Alzheimer’s disease	5
Promising biomarkers of Kawasaki disease: markers that aid in diagnosis	5
Challenges in diagnosing hydatidiform moles: a review of promising molecular biomarkers	5
Clinical utilization of airway inflammatory biomarkers in the prediction and monitoring of clinical outcomes in patients with chronic obstructive pulmonary disease	4
We have reached single-visit testing, diagnosis, and treatment for hepatitis C infection, now what?	4
How can we improve the successful identification of patients suitable for CAR-T cell therapy?	4
Evaluation of ctDNA-based ESR1 testing in breast cancer: results from the first external quality assessment scheme in China	4
The potential diagnostic value of extracellular vesicle miRNA for human non-small cell lung cancer: a systematic review and meta-analysis	4
[ 68 Ga]PSMA-11 for positron emission tomography (PET) imaging of prostate-specific membrane antigen (PSMA)-positive lesions in men with prostate cancer	4
Blood concentrations of proapoptotic sFas and antiapoptotic Bcl2 and COVID-19 patient mortality	4
Clinical value of identifying genes that inhibit hepatocellular carcinomas	4
Potential of CRISPR/Cas system in the diagnosis of COVID-19 infection	4
Combined exome analysis and exome depth assessment achieve a high diagnostic yield in an epilepsy case series, revealing significant genomic heterogeneity and novel mechanisms	4
Highly sensitive droplet digital PCR-based diagnostics for the surveillance of malaria vector populations in low transmission and incipient resistance settings	4
Are we closer to robust predictors of recurrent pregnancy loss by means of integrating different types of omics data?	4
Gestational trophoblastic disease: STR genotyping for precision diagnosis	4
Promotor methylation in ocular surface squamous neoplasia development: epigenetics implications in molecular diagnosis	4
Comet-FISH analysis of urothelial cells. A screening opportunity for bladder cancer?	4
The emerging role of liquid biopsy in oral squamous cell carcinoma detection: advantages and challenges	4
Lost in translation: the pitfalls of Ensembl gene annotations between human genome assemblies and their impact on diagnostics	4
Advances in RT-LAMP for COVID-19 testing and diagnosis	4
Blood soluble Fas concentrations and ischemic stroke patient mortality	4
Research advancement in fluid biomarkers for Parkinson’s disease	4
Paving the way for quality assured, decentralised point-of-care testing for infectious disease in primary care - Real world lessons from remote Australia	4
Detection of SARS-CoV-2 in tissue: the comparative roles of RT-qPCR, in situ RNA hybridization, and immunohistochemistry	4
Predictive biomarkers for systemic therapy of hepatocellular carcinoma	4
Genetic variant in LncRNA-NKILA associated with gastric cancer susceptibility and the binding with miR-6731-5p	4
Evaluation of transcriptomic molecular classification, biological behavior, and clinicopathological features in hepatocellular carcinoma	4
Next generation immuno-oncology biomarkers in gastrointestinal cancer: what does the future hold?	4
A review of the value of point-of-care testing for community-acquired pneumonia	3
Applications of ctDNA testing to monitor and detect residual disease in breast cancer	3
Circulating microRNA biomarkers in melanoma and non-melanoma skin cancer	3
Gastrin-releasing peptide receptor agonists and antagonists for molecular imaging of breast and prostate cancer: from pre-clinical studies to translational perspectives	3
Integrated nanophotonics - guiding molecular analysis out from the lab	3
Implementing Individualized quality control plans and managing risk at the point-of-care for molecular diagnostics	3
Circulating tumor cells as prognostic biomarkers in breast cancer: current status and future prospects	3
Serum Fas levels during first week of sepsis are associated with severity and mortality	3
Emerging prognostic biomarkers in advanced cutaneous melanoma: a literature update	3
Research tests for the diagnosis of tuberculosis infection	3
Advances in tests for colorectal cancer screening and diagnosis	3
Prognostic value of baculoviral IAP repeat containing 5 expression as a new biomarker in lung adenocarcinoma: a meta-analysis	3
Molecular biomarkers of blunt cardiac injury: recent advances and future perspectives	3
Association between the first and second trimester cell free DNA fetal fraction and spontaneous preterm birth	3
Perspective: cell death mechanisms and early diagnosis as precondition for disease modification in Parkinson’s disease: are we on the right track?	3
Clinical utility of reproductive carrier screening for preconception and pregnant couples for multiple genetic conditions: a systematic review and meta-analysis	3
Current status of diagnostic assays for emerging zoonotic viruses: Nipah and Hendra	3
The game changer: UCH-L1 and GFAP-based blood test as the first marketed in vitro diagnostic test for mild traumatic brain injury	3
Alpha-defensin does not provide additional benefit over leukocyte esterase in the diagnosis of periprosthetic joint infection	3
Brain exosomes as minuscule information hub for Autism Spectrum Disorder	3
Diagnosis and management of invasive fungal diseases by next-generation sequencing: are we there yet?	3
Quantifying SARS-CoV-2 viral load: current status and future prospects	3
Overview of point-of-care diagnostic options for detection of chlamydia trachomatis : current technology and implementation considerations	3
Point-of-care testing for viral-associated pulmonary aspergillosis	3
Analytical and clinical validation of an RNA sequencing-based assay for quantitative, accurate evaluation of a molecular signature response classifier in rheumatoid arthritis	3
Villin expression in human tumors: a tissue microarray study on 14,398 tumors	3